Sample size optimization and initial allocation of the significance levels in group sequential trials with multiple endpoints

被引:5
作者
Gou, Jiangtao [1 ]
机构
[1] Villanova Univ, Dept Math & Stat, Villanova, PA 19085 USA
关键词
multiple tests; multistage designs; power; sample size; trigger; CLOSED TESTING PROCEDURES; CLINICAL-TRIALS; DESIGN; BONFERRONI; FRAMEWORK; FAMILY; SIMES; POWER;
D O I
10.1002/bimj.202000081
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We consider multistage tests of multiple hypotheses under a flexible setting of calendar time and information fraction, focusing on the case where there are two hypotheses under testing. Explicit expressions of statistical powers are derived. With a proof of existence and uniqueness of solution, we develop a numerical method to search the optimal sample size. The proposed method allows us to find the suitable allocation of initial significance level along with the minimum sample size for group sequential designs, with and without hierarchical structures among different endpoints.
引用
收藏
页码:301 / 311
页数:11
相关论文
共 50 条
  • [41] Group-Sequential Strategies in Clinical Trials with Multiple Co-Primary Outcomes
    Hamasaki, Toshimitsu
    Asakura, Koko
    Evans, Scott R.
    Sugimoto, Tomoyuki
    Sozu, Takashi
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2015, 7 (01): : 36 - 54
  • [42] Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation
    Tamhane, Ajit C.
    Wu, Yi
    Mehta, Cyrus R.
    STATISTICS IN MEDICINE, 2012, 31 (19) : 2041 - 2054
  • [43] Sample size calculation for stepped-wedge cluster-randomized trials with more than two levels of clustering
    Teerenstra, Steven
    Taljaard, Monica
    Haenen, Anja
    Huis, Anita
    Atsma, Femke
    Rodwell, Laura
    Hulscher, Marlies
    CLINICAL TRIALS, 2019, 16 (03) : 225 - 236
  • [44] Blinded sample size reestimation in non-inferiority trials with binary Endpoints
    Friede, Tim
    Mitchell, Charles
    Mueller-Velten, Guenther
    BIOMETRICAL JOURNAL, 2007, 49 (06) : 903 - 916
  • [45] Sample Size Calculation for "Gold-Standard" Noninferiority Trials With Fixed Margins and Negative Binomial Endpoints
    Homma, Gosuke
    Daimon, Takashi
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2021, 13 (04): : 435 - 447
  • [46] Information-based sample size re-estimation in group sequential design for longitudinal trials
    Zhou, Jing
    Adewale, Adeniyi
    Shentu, Yue
    Liu, Jiajun
    Anderson, Keaven
    STATISTICS IN MEDICINE, 2014, 33 (22) : 3801 - 3814
  • [47] Sequential Testing to Guarantee the Necessary Sample Size in Clinical Trials
    Rukhin, Andrew L.
    COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 2009, 38 (16-17) : 3114 - 3122
  • [48] Sample Size Issues for Cluster Randomized Trials With Discrete-Time Survival Endpoints
    Moerbeek, Mirjam
    METHODOLOGY-EUROPEAN JOURNAL OF RESEARCH METHODS FOR THE BEHAVIORAL AND SOCIAL SCIENCES, 2012, 8 (04) : 146 - 158
  • [49] A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials
    Bowden, J.
    Mander, A.
    PHARMACEUTICAL STATISTICS, 2014, 13 (03) : 163 - 172
  • [50] Development of Adaptive Group Sequential Procedure for Changing Sample Size
    Nakamura, Tomohiro
    Douke, Hideyuki
    COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION, 2010, 39 (05) : 950 - 970